1. Home
  2. RCUS vs GETY Comparison

RCUS vs GETY Comparison

Compare RCUS & GETY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RCUS
  • GETY
  • Stock Information
  • Founded
  • RCUS 2015
  • GETY 1995
  • Country
  • RCUS United States
  • GETY United States
  • Employees
  • RCUS N/A
  • GETY N/A
  • Industry
  • RCUS Biotechnology: Pharmaceutical Preparations
  • GETY Industrial Machinery/Components
  • Sector
  • RCUS Health Care
  • GETY Industrials
  • Exchange
  • RCUS Nasdaq
  • GETY Nasdaq
  • Market Cap
  • RCUS 1.4B
  • GETY 1.6B
  • IPO Year
  • RCUS 2018
  • GETY N/A
  • Fundamental
  • Price
  • RCUS $14.35
  • GETY $2.84
  • Analyst Decision
  • RCUS Buy
  • GETY Strong Buy
  • Analyst Count
  • RCUS 12
  • GETY 4
  • Target Price
  • RCUS $34.50
  • GETY $5.61
  • AVG Volume (30 Days)
  • RCUS 835.5K
  • GETY 432.7K
  • Earning Date
  • RCUS 11-06-2024
  • GETY 11-07-2024
  • Dividend Yield
  • RCUS N/A
  • GETY N/A
  • EPS Growth
  • RCUS N/A
  • GETY N/A
  • EPS
  • RCUS N/A
  • GETY 0.13
  • Revenue
  • RCUS $263,000,000.00
  • GETY $917,902,000.00
  • Revenue This Year
  • RCUS $112.97
  • GETY $3.79
  • Revenue Next Year
  • RCUS N/A
  • GETY $2.37
  • P/E Ratio
  • RCUS N/A
  • GETY $22.16
  • Revenue Growth
  • RCUS 119.17
  • GETY N/A
  • 52 Week Low
  • RCUS $13.50
  • GETY $2.83
  • 52 Week High
  • RCUS $20.31
  • GETY $5.77
  • Technical
  • Relative Strength Index (RSI)
  • RCUS 37.76
  • GETY 27.13
  • Support Level
  • RCUS $14.19
  • GETY $2.81
  • Resistance Level
  • RCUS $15.01
  • GETY $3.56
  • Average True Range (ATR)
  • RCUS 0.98
  • GETY 0.22
  • MACD
  • RCUS -0.22
  • GETY -0.12
  • Stochastic Oscillator
  • RCUS 7.41
  • GETY 0.59

About RCUS Arcus Biosciences Inc.

Arcus Biosciences Inc is a clinical-stage biopharmaceutical company. It develops immunotherapies for the treatment of cancer. The company focuses on an ATP-adenosine pathway, which is a key driver of immunosuppression in the tumor microenvironment to create and optimize differentiated small-molecule immuno-oncology product candidates. Its product pipeline includes Domvanalimab, Etrumadenant, AB598, Casdatifan among others. Arcus conducts clinical trials for different types of cancers such as Lung, Colorectal, Pancreatic, and others. The company operates through a single segment which is the business of developing and commercializing immunotherapies.

About GETY Getty Images Holdings Inc.

Getty Images Holdings Inc is engaged in the core mission of bringing the world's creative and editorial visual content solutions to its customers to engage their audiences. the company has developed market enhancements across e-commerce, content subscriptions, user-generated content, diverse and inclusive content, and proprietary research alongside investment in its technology platform, which includes artificial intelligence and machine learning-driven search functionality and image editing and integrated APIs, to become a trusted industry leader in the visual content. Geographically the company operates in the Americas, Europe, the Middle East, Africa, and Asia-Pacific, out of which a majority of its revenue is generated from the Americas.

Share on Social Networks: